| Literature DB >> 33783673 |
Brenda Kanu1,2, Grace S N Kia3,4, Idowu A Aimola5,3, George C Korie5,3, Ishaya S Tekki6.
Abstract
Infection with the deadly rabies virus (RABV) leads to alteration of cellular gene expression. The RABV, similar to other neurodegenerative diseases may be implicated in neuronal death due to an imbalance in Ca2+ homeostasis. Parvalbumin (PV) and Secretagogin (Scgn), two members of the Calcium-Binding Proteins (CBPs) are useful neuronal markers responsible for calcium regulation and buffering with possible protective roles against infections. This study investigated whether infection with rabies virus causes variance in expression levels of PV and Scgn using the Challenge virus standard (CVS) and Nigerian Street Rabies virus (SRV) strains. Forty-eight, 4-week-old BALB/c mice strains were divided into two test groups and challenged with Rabies virus (RABV) infection and one control group. The presence of RABV antigen was verified by direct fluorescent antibody test (DFAT) and real-time quantitative PCR (qRT-PCR) was used to assess PV and Scgn gene expression. Infection with both virus strains resulted in significant (p < 0.05) increases in expression during early infection. Mid-infection phase caused reduced expression for both genes. However, as infection progressed to the terminal phase, a lower increase in expression was measured. Gene expression and viral load correlation indicated no positive relationship. Neurons with these CBPs may have a greater capacity to buffer calcium and be more resistant to degenerative changes caused by RABV. This implies that, when PV and Scgn expression levels are kept adequately high, the integrity of neurons may be maintained and degeneration caused by RABV infection may be prevented or stopped, hence, these are possible constituents of effective rabies therapy.Entities:
Keywords: Calcium-binding protein; Gene expression; Parvalbumin; Rabies virus; Secretagogin
Mesh:
Substances:
Year: 2021 PMID: 33783673 PMCID: PMC8008021 DOI: 10.1007/s11011-021-00717-4
Source DB: PubMed Journal: Metab Brain Dis ISSN: 0885-7490 Impact factor: 3.655
Primers used for qRT-PCR
| Gene | Gene Accession Number | Primers (5′-3′) |
|---|---|---|
| X54613.1 | Forward: 5’-TTGAGGAGGATGAGCTGGGGTCCA-3′ | |
Reverse: 5’-AACCCCAATCTTGCCGTCCCATC-3′ | ||
| NM_145399.1 | Forward: 5’-CCTGGAAGGCCCAGAAGTGGATGG-3′ | |
Reverse: 5’-ATGGCGAAGCAGAATCTCCCGGAAC-3′ | ||
| NM_008828.3 | Forward: 5’-ATGCCGAGGCTGTGGGTCGAG-3′ | |
Reverse: 5’-ACTTGGTTCCCCTGGCAAAGGCT-3′ |
Primers used in viral load determination
| Gene | Gene Accession Number | Primers (5′-3′) |
|---|---|---|
CVSA (Outer Primer) | KR105374.1 | Forward: 5’-GGCACAGTCGTCACCGCTTA-3’ |
| Reverse: 5’-TGAGGGGCACATGCAGCAAT-3’ | ||
RAV (Outer Primer) | NM_008828.3 | Forward: 5’-GCTCTGGGCTGGTGTCGTTC-3’ |
| Reverse: 5’-TACGGGGACTTCCCGCTCAG-3’ | ||
CVSN (Nested Primer) | KR105374.1 | Forward: 5’-AGAAGAATGTTCGAGCCAGGGGCAAG-3’ |
Reverse: 5’-AGGAGACTTCCCACTCAAGCCTAGTG-3’ | ||
RAVN (Nested Primer) | KR080523.1 | Forward: 5’-AGAATGTTCGAGCCAGGGCAGGAC-3’ Reverse: 5’-ACTTCCCGCTCAGACCCAACGAG-3’ |
*CVSA, CVSN: Used for amplification of CVS-11 viral strain
*RAV, RAVN: Used for amplification of SRV viral strain
Antigen detection and Clinical manifestations in CVS and SRV infected mice
| Clinical Signs | ||||
|---|---|---|---|---|
| Days Post Infection | Antigen Detection | Ruffled Fur | Increased Agitation | Paralysis |
| – | – | – | – | |
| + | + | – | – | |
| + | + | + | – | |
| + | + | + | + | |
| + | + | + | + | |
| + | + | + | + | |
| – | – | – | – | |
| + | – | – | – | |
| + | + | – | – | |
| + | + | + | – | |
| + | + | + | + | |
| + | + | + | + | |
Fig. 1Parvalbumin fold change in expression in CVS-11 and SRV infected mice, relative to PGK-1. The brains from uninfected controls as well as from both CVS-11 and SRV infected mice were collected at days 3, 6, 9, 12, 15, and 18 p.i, and RNA was isolated for qPCR as detailed in Materials and Methods. The relative fold changes are expressed in the graph, values marked * are statistically significant (p < 0.05) from controls. PGK-1: Phosphoglycerate kinase-1, CVS-11: Challenge virus standard, SRV: Street rabies virus
Fig. 2Secretagogin fold change in expression in CVS-11 and SRV infected mice, relative to PGK-1. The brains from uninfected controls as well as from both CVS-11 and SRV infected mice were collected at days 3, 6, 9, 12, 15, and 18 p.i, and RNA was isolated for qPCR as detailed in Materials and Methods. The relative fold changes are expressed in the graph, values marked * are statistically significant (p < 0.05) from controls. PGK-1: Phosphoglycerate kinase-1, CVS-11: Challenge virus standard, SRV: Street rabies virus
Viral load Quantification in CVS-11 and SRV infected mouse brain tissue samples
| CVS | SRV | |
|---|---|---|
| Days Post Infection | Average Viral Load (Copies/30 mg of brain tissue) | Average Viral Load (Copies/30 mg of brain tissue) |
| 3 | 2.13 × 1024 ± 9.3.× 1023 | 3.31 × 1018 ± 7.41 × 1017 |
| 6 | 1.17 × 1028 ± 4.16 × 1027 | 1.11 × 1019 ± 1.50 × 1018 |
| 9 | 2.34 × 1035 ± 6.27 × 1034 | 1.72 × 1022 ± 6.10 × 1021 |
| 12 | 2.34 × 1056 ± 6.27 × 1055 | 4.48 × 1024 ± 3.29 × 1024 |
| 15 | 2.25 × 1057 ± 7.8 × 1056 | 8.32 × 1032 ± 1.50 × 1032 |
| 18 | 6.40 × 1051 ± 5.79 × 1050 | 4.76 × 1032 ± 2.31 × 1032 |
Relationship between expression and Viral Load for PV and Scgn in CVS-11 and SRV infected samples
| Parvalbumin | Secretagogin | |||
|---|---|---|---|---|
| Strains | Pearson Correlation | Pearson Correlation | ||
| CVS-11 | −0.696 | 0.125 | −0.352 | 0.494 |
| SRV | −0.379 | 0.458 | 0.290 | 0.577 |